Coherus Oncology (CHRS) Price to Book Value: 2.166

Coherus Oncology, Inc. (CHRS)

0.853 +0.05 (+5.88%) USD | NASDAQ | Nov 04, 16:00

0.8964 +0.04 (+5.09%) After-Hours: 20:00

Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2014. Start Trial.

Date	Value
November 03, 2026	2.045
November 02, 2026	1.903
October 30, 2026	2.108
October 29, 2026	2.281
October 28, 2026	2.945
October 27, 2026	2.717
October 26, 2026	2.564
October 23, 2026	2.564
October 22, 2026	2.666
October 21, 2026	2.590
October 20, 2026	2.539
October 19, 2026	2.434
October 16, 2026	2.514
October 15, 2026	2.717
October 14, 2026	2.666
October 13, 2026	2.717
October 12, 2026	2.615
October 09, 2026	2.717
October 08, 2026	2.717
October 07, 2026	2.564
October 06, 2026	2.615
October 05, 2026	2.844
October 02, 2026	2.945
October 01, 2026	2.945
September 30, 2026	3.072

Date	Value
September 29, 2026	2.996
September 28, 2026	2.894
September 25, 2026	2.869
September 24, 2026	2.971
September 23, 2026	3.199
September 22, 2026	3.301
September 21, 2026	3.478
September 18, 2026	3.428
September 17, 2026	3.123
September 16, 2026	3.098
September 15, 2026	3.377
September 14, 2026	3.631
September 11, 2026	3.377
September 10, 2026	3.402
September 09, 2026	3.352
September 08, 2026	3.478
September 04, 2026	3.605
September 03, 2026	3.478
September 02, 2026	3.605
September 01, 2026	3.478
August 31, 2026	3.428
August 28, 2026	3.58
August 27, 2026	3.707
August 26, 2026	3.682
August 25, 2026	3.478

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks